Client News

After seven years of accelerated growth at Rentschler Biopharma SE under his leadership as CEO, Dr. Frank Mathias to return to the Supervisory Board

Element Materials Unveils One of the First and Largest Air Treatment Testing Facilities Designed to Support Indoor Space Public Health Air Quality

Lindis Blood Care Establishes Scientific Advisory Board of Leading Industry Experts

Rentschler Biopharma appoints Christiane Bardroff as Chief Operating Officer and Member of the Executive Board

ABIVAX RELEASES THE RESULTS OF ITS NOVEMBER 9, 2022 AD HOC ORDINARY AND EXTRAORDINARY GENERAL MEETING

Destiny Pharma: XF-73 Dermal infection project advances into clinically enabling safety study with US Government’s NIAID

Mainz Biomed Announces U.S. Extension of ColoFuture Study to Evaluate Integration of Novel mRNA Biomarkers into ColoAlert

LINDIS Biotech Presented Encouraging Data from High Risk-Non-Muscle-Invasive Bladder Cancer Patients Treated with Trifunctional Antibody CATUMAXOMAB at EMUC22

invIOs presents positive patient data from ongoing Phase 1b trial of APN401 cell therapy in advanced solid tumors at SITC 2022

ONWARD’s Research Partner .NeuroRestore Publishes Groundbreaking Paper Identifying Neurons that Restore Walking after Paralysis